{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:45:21Z","timestamp":1791895521838,"version":"4.3.4"},"reference-count":54,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2100,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1002\/hep.23222","type":"journal-article","created":{"date-parts":[[2009,8,11]],"date-time":"2009-08-11T07:49:21Z","timestamp":1249976961000},"page":"1924-1935","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":60,"title":["Role of \u03b23\u2010adrenoceptors for intrahepatic resistance and portal hypertension in liver cirrhosis\u2020"],"prefix":"10.1097","volume":"50","author":[{"given":"Jonel","family":"Trebicka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Hennenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Schulze Pr\u00f6bsting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Laleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Granzow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Nevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Zaagsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Heller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilman","family":"Sauerbruch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-28-20241201","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1055\/s-2007-1007126","article-title":"Liver microvascular architecture: an insight into the pathophysiology of portal hypertension","volume":"19","author":"Ekataksin","year":"1999","journal-title":"Semin Liver Dis"},{"key":"R2-28-20241201","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1136\/gut.2007.144584","article-title":"Mechanisms of extrahepatic vasodilation in portal hypertension","volume":"57","author":"Hennenberg","year":"2008","journal-title":"Gut"},{"key":"R3-28-20241201","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/hep.21673","article-title":"Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA\/Rho\u2010kinase and activation of endothelial nitric oxide synthase","volume":"46","author":"Trebicka","year":"2007","journal-title":"HEPATOLOGY"},{"key":"R4-28-20241201","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/hep.22170","article-title":"Hemodynamic effects of urotensin II and its specific receptor antagonist palosuran in cirrhotic rats","volume":"47","author":"Trebicka","year":"2008","journal-title":"HEPATOLOGY"},{"key":"R5-28-20241201","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1053\/j.gastro.2005.11.029","article-title":"Defective RhoA\/Rho\u2010kinase signaling contributes to vascular hypocontractility and vasodilation in cirrhotic rats","volume":"130","author":"Hennenberg","year":"2006","journal-title":"Gastroenterology"},{"key":"R6-28-20241201","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/hep.21502","article-title":"Vascular dysfunction in human and rat cirrhosis: role of receptor\u2010desensitizing and calcium\u2010sensitizing proteins","volume":"45","author":"Hennenberg","year":"2007","journal-title":"HEPATOLOGY"},{"key":"R7-28-20241201","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1136\/gut.2005.081059","article-title":"Intrahepatic upregulation of RhoA and Rho\u2010kinase signalling contributes to increased hepatic vascular resistance in rats with secondary biliary cirrhosis","volume":"55","author":"Zhou","year":"2006","journal-title":"Gut"},{"key":"R8-28-20241201","first-page":"141","article-title":"Complications of cirrhosis","volume":"32","author":"Bosch","year":"2000","journal-title":"I. Portal hypertension. J Hepatol"},{"key":"R9-28-20241201","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1478-3231.2005.01053.x","article-title":"Vascular, hemodynamic and renal effects of low\u2010dose losartan in rats with secondary biliary cirrhosis","volume":"25","author":"Heller","year":"2005","journal-title":"Liver Int"},{"key":"R10-28-20241201","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/hep.1840020502","article-title":"The effect of propranolol on portal hypertension in patients with cirrhosis: a hemodynamic study","volume":"2","author":"Lebrec","year":"1982","journal-title":"HEPATOLOGY"},{"key":"R11-28-20241201","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1056\/NEJM199508103330605","article-title":"Genetic variation in the beta 3\u2010adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity","volume":"333","author":"Clement","year":"1995","journal-title":"N Engl J Med"},{"key":"R12-28-20241201","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1079\/PNS19890032","article-title":"The brown adipocyte beta\u2010adrenoceptor","volume":"48","author":"Arch","year":"1989","journal-title":"Proc Nutr Soc"},{"key":"R13-28-20241201","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0165-6147(90)90032-4","article-title":"Is the adipocyte beta\u2010adrenoceptor a prototype for the recently cloned atypical <5001>beta 3\u2010adrenoceptor<5002>?","volume":"11","author":"Zaagsma","year":"1990","journal-title":"Trends Pharmacol Sci"},{"key":"R14-28-20241201","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1172\/JCI118823","article-title":"Functional beta3\u2010adrenoceptor in the human heart","volume":"98","author":"Gauthier","year":"1996","journal-title":"J Clin Invest"},{"key":"R15-28-20241201","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1161\/01.CIR.103.12.1649","article-title":"Upregulation of beta (3)\u2010adrenoceptors and altered contractile response to inotropic amines in human failing myocardium","volume":"103","author":"Moniotte","year":"2001","journal-title":"Circulation"},{"key":"R16-28-20241201","doi-asserted-by":"crossref","first-page":"H2425","DOI":"10.1152\/ajpheart.01045.2003","article-title":"Endogenous beta3\u2010adrenoreceptor activation contributes to left ventricular and cardiomyocyte dysfunction in heart failure","volume":"286","author":"Morimoto","year":"2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R17-28-20241201","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ejphar.2003.09.037","article-title":"Characterization of beta 3\u2010adrenoceptor\u2010mediated relaxation in rat abdominal aorta smooth muscle","volume":"482","author":"Matsushita","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"R18-28-20241201","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/sj.bjp.0704867","article-title":"Beta 3\u2010adrenoceptor in rat aorta: molecular and biochemical characterization and signalling pathway","volume":"137","author":"Rautureau","year":"2002","journal-title":"Br J Pharmacol"},{"key":"R19-28-20241201","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1161\/CIRCULATIONAHA.104.532960","article-title":"Endothelial beta3\u2010adrenoreceptors mediate nitric oxide\u2010dependent vasorelaxation of coronary microvessels in response to the third\u2010generation beta\u2010blocker nebivolol","volume":"112","author":"Dessy","year":"2005","journal-title":"Circulation"},{"key":"R20-28-20241201","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1476-5381.1996.tb15209.x","article-title":"Functional identification of rat atypical beta\u2010adrenoceptors by the first beta 3\u2010selective antagonists, aryloxypropanolaminotetralins","volume":"117","author":"Manara","year":"1996","journal-title":"Br J Pharmacol"},{"key":"R21-28-20241201","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1476-5381.1993.tb13830.x","article-title":"The beta\u2010adrenoceptors mediating relaxation of rat oesophageal muscularis mucosae are predominantly of the beta 3\u2010, but also of the beta 2\u2010subtype","volume":"110","author":"de Boer","year":"1993","journal-title":"Br J Pharmacol"},{"key":"R22-28-20241201","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0898-6568(94)90085-X","article-title":"Differential recruitment and differential regulation by physiological amines of fat cell beta\u20101, beta\u20102 and beta\u20103 adrenergic receptors expressed in native fat cells and in transfected cell lines","volume":"6","author":"Lafontan","year":"1994","journal-title":"Cell Signal"},{"key":"R23-28-20241201","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1472-8206.1995.tb00268.x","article-title":"Regulation of beta 3\u2010adrenoceptor expression in white fat cells","volume":"9","author":"Langin","year":"1995","journal-title":"Fundam Clin Pharmacol"},{"key":"R24-28-20241201","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0898-6568(94)90093-0","article-title":"Differential interaction of beta 1\u2010 and beta 3\u2010adrenergic receptors with Gi in rat adipocytes","volume":"6","author":"Chaudhry","year":"1994","journal-title":"Cell Signal"},{"key":"R25-28-20241201","doi-asserted-by":"crossref","first-page":"13148","DOI":"10.1016\/S0021-9258(17)36811-4","article-title":"Cell\u2010specific down\u2010regulation of the beta 3\u2010adrenergic receptor","volume":"269","author":"Nantel","year":"1994","journal-title":"J Biol Chem"},{"key":"R26-28-20241201","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0022-3565(25)38450-8","article-title":"Peripheral vascular effects of beta\u20103 adrenergic receptor stimulation in conscious dogs","volume":"268","author":"Shen","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"R27-28-20241201","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/S0022-3565(25)20798-4","article-title":"Differences in beta 3\u2010adrenergic receptor cardiovascular regulation in conscious primates, rats and dogs","volume":"278","author":"Shen","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"R28-28-20241201","first-page":"193","article-title":"Beta 3\u2010adrenoceptors in the cardiovascular system","volume":"37","author":"Gauthier","year":"2007","journal-title":"Clin Hemorheol Microcirc"},{"key":"R29-28-20241201","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1476-5381.1991.tb12215.x","article-title":"Relationship between lipolysis and cyclic AMP generation mediated by atypical beta\u2010adrenoceptors in rat adipocytes","volume":"102","author":"Hollenga","year":"1991","journal-title":"Br J Pharmacol"},{"key":"R30-28-20241201","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1006\/bbrc.1998.9047","article-title":"Atypical adrenoceptor\u2010mediated relaxation of canine pulmonary artery through a cAMP\u2010dependent pathway","volume":"248","author":"Tamaoki","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"R31-28-20241201","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1161\/hc4501.098933","article-title":"Augmentation of cardiac contractility mediated by the human beta (3)\u2010adrenergic receptor overexpressed in the hearts of transgenic mice","volume":"104","author":"Kohout","year":"2001","journal-title":"Circulation"},{"key":"R32-28-20241201","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jacc.2005.03.061","article-title":"Characterization of beta3\u2010adrenoceptors in human internal mammary artery and putative involvement in coronary artery bypass management","volume":"46","author":"Rozec","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"R33-28-20241201","doi-asserted-by":"crossref","first-page":"5531","DOI":"10.1073\/pnas.0931347100","article-title":"Involvement of beta 3\u2010adrenergic receptor activation via cyclic GMP\u2010 but not NO\u2010dependent mechanisms in human corpus cavernosum function","volume":"100","author":"Cirino","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R34-28-20241201","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/0016-5085(93)90655-V","article-title":"Role of nitric oxide in the in vitro splanchnic vascular hyporeactivity in ascitic cirrhotic rats","volume":"104","author":"Sieber","year":"1993","journal-title":"Gastroenterology"},{"key":"R35-28-20241201","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00210-003-0860-y","article-title":"Comparative pharmacology of human beta\u2010adrenergic receptor subtypes\u2014characterization of stably transfected receptors in CHO cells","volume":"369","author":"Hoffmann","year":"2004","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"R36-28-20241201","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/sj.bjp.0706369","article-title":"Direct demonstration of beta1\u2010 and evidence against beta2\u2010 and beta3\u2010adrenoceptors, in smooth muscle cells of rat small mesenteric arteries","volume":"146","author":"Briones","year":"2005","journal-title":"Br J Pharmacol"},{"key":"R37-28-20241201","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00210-005-1067-1","article-title":"Comparison of the alpha\u2010adrenoceptor\u2010mediated effects of beta3\u2010adrenoceptor ligands in rat pulmonary artery","volume":"371","author":"Leblais","year":"2005","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"R38-28-20241201","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00210-006-0127-5","article-title":"Tools to study beta3\u2010adrenoceptors","volume":"374","author":"Vrydag","year":"2007","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"R39-28-20241201","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1053\/j.gastro.2006.12.041","article-title":"Nitroflurbiprofen, a nitric oxide\u2010releasing cyclooxygenase inhibitor, improves cirrhotic portal hypertension in rats","volume":"132","author":"Laleman","year":"2007","journal-title":"Gastroenterology"},{"key":"R40-28-20241201","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0091-679X(08)61797-5","article-title":"Preparation of isolated rat liver cells","volume":"13","author":"Seglen","year":"1976","journal-title":"Methods Cell Biol"},{"key":"R41-28-20241201","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1053\/jhep.2002.31432","article-title":"The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough","volume":"35","author":"Wiest","year":"2002","journal-title":"HEPATOLOGY"},{"key":"R42-28-20241201","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0163-7258(01)00123-1","article-title":"Characterisation of portal hypertension models by microspheres in anaesthetised rats: a comparison of liver flow","volume":"90","author":"Van de Casteele","year":"2001","journal-title":"Pharmacol Ther"},{"key":"R43-28-20241201","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0008-6363(96)88549-X","article-title":"Measurement of organ blood flow with coloured microspheres in the rat","volume":"29","author":"Hakkinen","year":"1995","journal-title":"Cardiovasc Res"},{"key":"R44-28-20241201","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1476-5381.1996.tb15207.x","article-title":"Modulation of agonist\u2010induced phosphoinositide metabolism, Ca2+ signalling and contraction of airway smooth muscle by cyclic AMP\u2010dependent mechanisms","volume":"117","author":"Hoiting","year":"1996","journal-title":"Br J Pharmacol"},{"key":"R45-28-20241201","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J Clin Invest"},{"key":"R46-28-20241201","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","article-title":"Mechanisms of hepatic fibrogenesis","volume":"134","author":"Friedman","year":"2008","journal-title":"Gastroenterology"},{"key":"R47-28-20241201","doi-asserted-by":"crossref","first-page":"G556","DOI":"10.1152\/ajpgi.00196.2006","article-title":"Both Ca2+\u2010dependent and \u2010independent pathways are involved in rat hepatic stellate cell contraction and intrahepatic hyperresponsiveness to methoxamine","volume":"292","author":"Laleman","year":"2007","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R48-28-20241201","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0022-3565(24)34951-1","article-title":"Interspecies differences in the cardiac negative inotropic effects of beta (3)\u2010adrenoceptor agonists","volume":"290","author":"Gauthier","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"R49-28-20241201","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/sj.bjp.0705840","article-title":"Alpha1\u2010adrenoceptor antagonist properties of CGP 12177A and other beta\u2010adrenoceptor ligands: evidence against beta (3)\u2010 or atypical beta\u2010adrenoceptors in rat aorta","volume":"142","author":"Brahmadevara","year":"2004","journal-title":"Br J Pharmacol"},{"key":"R50-28-20241201","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1172\/JCI116891","article-title":"Reduced beta 1 receptor messenger RNA abundance in the failing human heart","volume":"92","author":"Bristow","year":"1993","journal-title":"J Clin Invest"},{"key":"R51-28-20241201","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1136\/gut.2003.026658","article-title":"Hepatic fibrogenesis requires sympathetic neurotransmitters","volume":"53","author":"Oben","year":"2004","journal-title":"Gut"},{"key":"R52-28-20241201","doi-asserted-by":"crossref","first-page":"G877","DOI":"10.1152\/ajpgi.00537.2005","article-title":"Norepinephrine induces calcium spikes and proinflammatory actions in human hepatic stellate cells","volume":"291","author":"Sancho\u2010Bru","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R53-28-20241201","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/00000542-198412000-00010","article-title":"Anesthetic influences on regional hemodynamics in normal and hemorrhaged rats","volume":"61","author":"Seyde","year":"1984","journal-title":"Anesthesiology"},{"key":"R54-28-20241201","first-page":"G52","article-title":"Portal venous pressure and portasystemic shunting in experimental portal hypertension","volume":"257","author":"Geraghty","year":"1989","journal-title":"Am J Physiol"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.23222","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-200912000-00028","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T18:24:31Z","timestamp":1739298271000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-200912000-00028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":54,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.23222","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}